Genespire is a biotechnology company focused on the development of durable and transformative gene therapies for patients affected by genetic diseases, particularly primary immunodeficiencies and inherited metabolic diseases. Based in Milan, Italy, Genespire was founded in March 2020 by the gene therapy pioneer Prof. Luigi Naldini, Dr. Alessio Cantore, Fondazione Telethon and Ospedale San Raffaele. It is a spin-off of SR-Tiget, a world leading cell and gene therapy research institute and is backed by Sofinnova Partners.
Location: Italy, Lombardy, Milan
Member count: 1-10
Total raised: $17.403941M
Founded date: 2020
Investors 1
| Date | Name | Website |
| - | Sofinnova ... | sofinnovap... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 29.04.2020 | Series A | $17.403941... | - | finsmes.co... |
Mentions in press and media 5
| Date | Title | Description | Category | Author | Source |
| 07.07.2022 | Genespire ... | Genespire appoints Dr. Sabah S... | - | - | globenewsw... |
| 13.07.2021 | Genespire ... | Genespire appoints Philippe Ma... | - | - | marketscre... |
| 10.08.2020 | These aspi... | The tech startup ecosystem in ... | featured ... | Editorial ... | siliconcan... |
| 30.04.2020 | Daily fund... | Resistant AI landed $2.75M; Gu... | - | Kristin Ka... | vator.tv/n... |
| 29.04.2020 | Genespire ... | Genespire, a Milan, Italy-base... | Italy | - | finsmes.co... |